By Jon Chesto It took longer than expected,but The Davis Companies’ big bet on Watertown Square is paying off with the region’s largest lease deal for newly built lab space so far this year. Davis and its partner Boston Development Group just inked a deal with serial biotech entrepreneur Greg Verdine that would bring two of Verdine’s […]
By Hannah Green Last year, Massachusetts’ life sciences industry saw its slowest job growth since 2017 as the industry faced economic headwinds. The Bay State’s biopharma workforce consisted of 116,937 employees in 2023, according to the latest “Industry Snapshot” report put out by the Massachusetts Biotechnology Council, or MassBio, on Tuesday. The trade group found that […]
The Biosecure Act could ban Chinese biotechs and hurt Mass. drug developers. But some see an opportunity for local R&D.By Hannah Green Driven by concerns over national security, the federal government is weighing a crackdown on Chinese biotechnology suppliers that would have far-reaching effects in the life sciences industry. The legislation, known as the Biosecure Act, would prevent biotech […]
By Jon Chesto When demand for office space cratered during the COVID-19 pandemic, many developersdoubled down on building lab space instead. Lately, it sure seems like they went overboard. With newly builtlife sciences buildings hitting the market at a much faster rate than they can be filled, the availability of lab space in Greater Boston […]
By Greg Ryan Five years ago, nearly half of the region’s lab space was in Cambridge, according to CBRE research. Today, about a third is. But a life sciences facility is not a “Field of Dreams.” Just because developers built labs in new places does not mean the biotechs will come — at least in this real estate market. […]
By Hannah Green Eli Lilly and Co. is buying a Waltham biotech in a deal valued at around $3.2 billion. The startup being acquired is Morphic Holding Inc. (NASDAQ: MORF), a Waltham company working on treatments for chronic diseases such as types of inflammatory bowel disease. Indianapolis-based Lilly (NYSE: LLY) plans to acquire all outstanding shares of […]
By Hannah Green Moderna Inc. officially opened the doors to its new global headquarters on Wednesday, fulfilling its plan to bring its research and development operations under one roof. The Cambridge drugmaker has moved into a six-floor, 462,000-square-foot office and lab building at 325 Binney St. Moderna (Nasdaq: MRNA) first shared its intention to move into a new Cambridge […]
By Hannah Green A Framingham-based biotech is relocating its headquarters to a new space closer to the center of Massachusetts’ biotech industry. BPGbio announced on Wednesday it was moving into 70,000 square feet of lab and office space at 300 Third Avenue in Waltham. The biotech company plans to move into two full floors of the […]
But as venture outlays fall, a recent spurt of layoffs has clouded outlook By Robert Weisman Globe Staff Massachusetts continued to expand its biopharma workforce in research labs and manufacturing plantslast year even as venture capital investment dwindled and fewer biotech companies went public. Overall employment in the sector — a bellwether of the state’s […]
President Joe Biden is infusing billions of dollars into a new, biotech-focused initiative, and it’s likely to have immediate ramifications for New England. Boston has long been a hotbed for pharmaceuticals in addition to upstart biotechs. But the White House is expanding the definition of what a “bioeconomy” could be, looking beyond drugmaking to other applications of […]
